Loading...
HSChapter 30
U.S. imports of antimalarial medicaments in measured doses for retail sale (HS 300460) totaled $192K in April 2026, traded with 5 countries.
Antimalarial Medicaments in Measured Doses for Retail Sale imports of $192K in April 2026 ran 28% below the year-to-date monthly average of $267K.
Last updated: April 2026 dataFinished-dose antimalarial preparations whose active ingredients are defined by Subheading Note 2 to Chapter 30 are classified under tariff line 3004600000. This heading was introduced in the HS 2017 revision to separately track artemisinin-based combination therapies (ACTs) and other priority antimalarials, reflecting global public health policy goals around access to these medicines. FDA regulates imported antimalarial drug products through its standard drug approval and foreign establishment registration framework, and importers should verify that the specific active ingredient qualifies under the applicable subheading note rather than defaulting to the residual 300490 heading. Supply chains for antimalarials often involve manufacturers in Asia, and importers should confirm that foreign establishments are on FDA's approved list prior to shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Classification in 300460 requires that the active antimalarial substance be one of those specifically enumerated in Subheading Note 2 to Chapter 30. Artemisinin derivatives and certain combination therapies are the primary targets of this note. If the active ingredient is not listed in that note, the product falls to the residual heading 300490. Importers should review the current Subheading Note text and consult a licensed customs broker to confirm eligibility.
Antimalarial medicaments are not broadly subject to Section 301 or antidumping measures as a category, but duty treatment can vary by country of origin. Importers should verify the current tariff schedule and any applicable trade-remedy orders for the specific country of manufacture, as pharmaceutical supply chains frequently involve multiple countries for API sourcing and finished-dose manufacturing. Consult a licensed customs broker for origin determination and admissibility review.
Supplier Network
Get discovered by U.S. importers searching for HS 300460 — Antimalarial Medicaments in Measured Doses for Retail Sale. Be the first supplier listed.
Monthly import values over time
| Country | Imports | Exports | Balance |
|---|---|---|---|
| SWITZERLAND | $192K | -- | -$192K |
| CANADA | -- | $150K | +$150K |
| UNITED KINGDOM | -- | $3K | +$3K |
| CHINA | -- | -- | -- |
| TURKEY | -- | -- | -- |
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % |
|---|---|---|---|
| 3004600000 | OTHER MEDS,ANTIMALARIAL IN SUBH NOTE 2,MEASURED | $192K | -- |
OTHER MEDS,ANTIMALARIAL IN SUBH NOTE 2,MEASURED
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004600000 | OTHER MEDS,ANTIMALARIAL IN SUBH NOTE 2,MEASURED | $153K |
OTHER MEDS,ANTIMALARIAL IN SUBH NOTE 2,MEASURED
398 kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| Port | Imports | Exports | Balance |
|---|---|---|---|
| SAVANNAH, GA | $192K | -- | -$192K |
| BUFFALO-NIAGARA FALLS, NY | -- | $150K | +$150K |
| NEW ORLEANS, LA | -- | $3K | +$3K |